Search Results

Press Releases

DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder

December 10, 2024

·

1 min read

Business

MMJ PhytoTech Ltd (ASX:MMJ) Annual Report to Shareholders

MMJ PhytoTech Ltd (ASX:MMJ) (OTCMKTS:MMJJF) provides the Company’s Annual Report to shareholders.

September 25, 2018

·

3 min read

Drug Development

MMJ PhytoTech Ltd PhytoTech Therapeutics Phase II Clinical Trial Update

MMJ PhytoTech is pleased to advise that it has received results from the first 10 patients who participated in the Phase 2 clinical trial undertaken by MMJ PhytoTech.

January 31, 2018

·

5 min read

Business

MMJ PhytoTech Ltd PhytoTech Therapeutics Ltd Management Changes

MMJ PhytoTech wishes to advise that Dr Daphna Heffetz, CEO of the Company’s subsidiary PTL, has tendered her resignation.

December 1, 2017

·

1 min read

Business

MMJ PhytoTech Ltd (ASX:MMJ) Ontario Cannabis Store Supply Agreements for Investee Companies

MMJ PhytoTech Limited attaches a copy of a news release by the Ontario Cannabis Store (“OCS”) confirming that it has entered into recreational cannabis supply agreements with a number of producers, including United Greeneries, a subsidiary of Harvest One Cannabis Inc.

September 10, 2018

·

1 min read

Policy

MMJ PhytoTech Ltd (ASX:MMJ) MediPharm Signs Customer Contracts Ahead of TSX-V Listing

MMJ PhytoTech Limited is pleased to note the attached three news releases by MediPharm Labs Inc (“MediPharm”) providing the details of three customer contracts signed over the past month or so and ahead of its listing on the TSX Venture Exchange (“TSX-V”) expected later this month.

September 10, 2018

·

1 min read

Drug Development

MMJ PhytoTech Ltd Phase I Clinical Trial Results Published in International Medical Journal

MMJ PhytoTech is pleased to advise that results from the Phase I Clinical Trial undertaken by MMJ’s PhytoTech Therapeutics have been published.

November 16, 2017

·

1 min read

Deals

MMJ PhytoTech Ltd to Acquire Strategic Position in Canadian Specialty Pharma and Healthcare Company Dosecann

MMJ PhytoTech is pleased to advise that it has entered into an agreement to acquire Dosecann via the proposed placement of C$2.5 million in secured convertible debenture units.

January 30, 2018

·

4 min read

Business

MMJ PhytoTech Ltd Quarterly Update and Appendix 4C

MMJ is pleased to provide its quarterly activities report for the period ended 30 September 2017, together with its Appendix 4C.

November 2, 2017

·

3 min read

MMJ PhytoTech Ltd Commits A$500,000 Cornerstone Investment in eSense-Lab Limited

MMJ will be issued 2,500,000 ordinary shares in eSense at the price of A$0.20 per share, and will receive 1 free option for every 2 shares issued at a $0.30 exercise price and expiry date of 3 years from date of issue.

November 14, 2017

·

4 min read